Get the Stockscreener App
8.25
3.12%
0.25
After Hours:
8.21
-0.04
-0.48%
Teladoc Health Inc stock is traded at $8.25, with a volume of 5.57M.
It is up +3.12% in the last 24 hours and up +7.42% over the past month.
Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with improved convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.
See More
Previous Close:
$8.00
Open:
$8.15
24h Volume:
5.57M
Relative Volume:
0.83
Market Cap:
$1.46B
Revenue:
$2.54B
Net Income/Loss:
$-207.36M
P/E Ratio:
-6.9328
EPS:
-1.19
Net Cash Flow:
$151.25M
1W Performance:
-3.73%
1M Performance:
+7.42%
6M Performance:
+13.79%
1Y Performance:
-10.33%
1-Day Range:
$7.985
$8.27
1-Week Range:
$7.985
$9.29
52-Week Range:
$6.35
$15.21
Teladoc Health Inc Stock (TDOC) Company Profile
Name
Teladoc Health Inc
Sector
Industry
Phone
(203) 635-2002
Address
155 E 44TH STREET, NEW YORK, NY
Compare TDOC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
8.25 | 1.41B | 2.54B | -207.36M | 151.25M | -1.19 |
|
VEEV
Veeva Systems Inc
|
286.09 | 46.97B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
94.47 | 16.75B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
67.50 | 12.29B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
93.23 | 7.80B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.16 | 6.81B | 906.14M | -52.62M | 89.62M | -0.3621 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-25-25 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Reiterated | Jefferies | Hold |
| Feb-29-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-17-24 | Downgrade | DA Davidson | Buy → Neutral |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Feb-23-23 | Upgrade | SVB Securities | Market Perform → Outperform |
| Oct-24-22 | Upgrade | Guggenheim | Sell → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-17-22 | Downgrade | Guggenheim | Neutral → Sell |
| Aug-12-22 | Initiated | DA Davidson | Buy |
| Aug-02-22 | Downgrade | Berenberg | Buy → Hold |
| Aug-02-22 | Downgrade | Cowen | Outperform → Market Perform |
| Jul-28-22 | Downgrade | Goldman | Buy → Neutral |
| Jul-28-22 | Downgrade | Needham | Buy → Hold |
| Jul-06-22 | Reiterated | BofA Securities | Neutral |
| May-05-22 | Downgrade | Argus | Buy → Hold |
| Apr-28-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-28-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-28-22 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-28-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-28-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-28-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-03-22 | Upgrade | Argus | Hold → Buy |
| Feb-23-22 | Reiterated | BofA Securities | Neutral |
| Feb-23-22 | Reiterated | Craig Hallum | Hold |
| Feb-23-22 | Reiterated | Evercore ISI | In-line |
| Feb-23-22 | Reiterated | Goldman | Buy |
| Feb-23-22 | Reiterated | JP Morgan | Overweight |
| Feb-23-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-23-22 | Reiterated | Needham | Buy |
| Feb-23-22 | Reiterated | Oppenheimer | Outperform |
| Feb-23-22 | Reiterated | Stifel | Hold |
| Feb-11-22 | Initiated | Goldman | Buy |
| Feb-08-22 | Reiterated | Piper Sandler | Overweight |
| Dec-02-21 | Resumed | Jefferies | Hold |
| Nov-22-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-28-21 | Reiterated | Barclays | Equal Weight |
| Oct-28-21 | Reiterated | BofA Securities | Neutral |
| Oct-28-21 | Reiterated | Canaccord Genuity | Buy |
| Oct-28-21 | Reiterated | Citigroup | Buy |
| Oct-28-21 | Reiterated | Craig Hallum | Hold |
| Oct-28-21 | Reiterated | Needham | Buy |
| Oct-28-21 | Reiterated | Oppenheimer | Outperform |
| Oct-28-21 | Reiterated | Piper Sandler | Overweight |
| Oct-28-21 | Reiterated | UBS | Neutral |
| Oct-19-21 | Initiated | Wells Fargo | Overweight |
| Aug-02-21 | Downgrade | Argus | Buy → Hold |
| Jul-28-21 | Downgrade | Deutsche Bank | Buy → Hold |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-15-21 | Initiated | Needham | Buy |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Dec-22-20 | Initiated | Evercore ISI | In-line |
| Dec-07-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Dec-04-20 | Initiated | Goldman | Neutral |
| Nov-13-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-22-20 | Initiated | DA Davidson | Buy |
| Sep-02-20 | Upgrade | Berenberg | Hold → Buy |
| Aug-17-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jul-13-20 | Initiated | Argus | Buy |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Apr-30-20 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
| Mar-25-20 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-16-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-12-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-28-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-12-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-10-20 | Initiated | UBS | Neutral |
| Jan-09-20 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Teladoc Health Inc Stock (TDOC) Latest News
How Teladoc Health Inc. stock valuations compare to rivalsWeekly Gains Report & Capital Efficient Trade Techniques - newser.com
Is Teladoc Health Inc. stock a safe buy before earnings2025 Trading Volume Trends & Accurate Trade Setup Notifications - newser.com
What data driven models say about Teladoc Health Inc.’s futureInsider Buying & Advanced Swing Trade Entry Plans - newser.com
Is Teladoc Health Inc. trending in predictive chart models2025 Geopolitical Influence & Detailed Earnings Play Alerts - newser.com
Forecasting Teladoc Health Inc. price range with options data2025 Price Momentum & Daily Market Momentum Tracking - newser.com
Will Teladoc Health Inc. rebound enough to break even2025 Trade Ideas & Scalable Portfolio Growth Ideas - newser.com
Is Teladoc Health Inc. forming a bottoming baseJuly 2025 Institutional & Fast Entry and Exit Trade Plans - newser.com
Using data filters to optimize entry into Teladoc Health Inc.July 2025 EndofMonth & Free Low Drawdown Momentum Trade Ideas - newser.com
Will Teladoc Health Inc. see short term momentumEarnings Overview Summary & Free High Accuracy Swing Entry Alerts - newser.com
Analyzing Teladoc Health Inc. with risk reward ratio chartsTrade Entry Summary & Weekly Setup with ROI Potential - newser.com
Is Teladoc Health Inc. building a consolidation baseBear Alert & Low Drawdown Momentum Ideas - newser.com
Applying chart zones and confluence areas to Teladoc Health Inc. - newser.com
Teladoc Health Inc. (TDOC) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
10 Best Online Therapy Services In 2025: Tried And Tested - Forbes
3 Medical Service Industry Stocks Poised to Counter Workforce Issues - Nasdaq
Tick level data insight on Teladoc Health Inc. volatilityJuly 2025 Institutional & Fast Momentum Stock Entry Tips - newser.com
Visualizing Teladoc Health Inc. stock with heatmapsBond Market & Long-Term Growth Portfolio Plans - newser.com
Why Teladoc Health Inc. stock could see breakout soonMarket Risk Analysis & Trade Opportunity Analysis Reports - newser.com
Telehealth Services Market Accelerating Remote Healthcare Delivery - openPR.com
Historical volatility pattern of Teladoc Health Inc. visualizedEarnings Risk Summary & Reliable Trade Execution Plans - newser.com
Why Teladoc Health Inc. (4LL) stock stays on top picksTrade Risk Report & Growth Oriented Trade Recommendations - newser.com
How interest rate cuts could boost Teladoc Health Inc. stockPortfolio Risk Report & Reliable Entry Point Trade Alerts - newser.com
Is Teladoc Health Inc. stock attractive for ETFsQuarterly Portfolio Review & Reliable Intraday Trade Plans - newser.com
Technical signs of recovery in Teladoc Health Inc.Product Launch & Safe Entry Trade Signal Reports - newser.com
Institutional scanner results for Teladoc Health Inc.July 2025 Patterns & Entry and Exit Point Strategies - newser.com
Will breakout in Teladoc Health Inc. lead to full recoveryTrade Performance Summary & Risk Controlled Swing Alerts - newser.com
What valuation ratios show for Teladoc Health Inc. (4LL) stockJuly 2025 Momentum & Short-Term Swing Trade Alerts - newser.com
Teladoc Health Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Evercore ISI Group Maintains Teladoc Health (TDOC) In-Line Recommendation - Nasdaq
Traders Purchase High Volume of Teladoc Health Call Options (NYSE:TDOC) - MarketBeat
Why Is Teladoc (TDOC) Stock Soaring Today - Yahoo Finance
Teladoc Health (NYSE:TDOC) Trading Up 9.6% on Analyst Upgrade - MarketBeat
TDOC: Evercore ISI Group Raises Price Target for Teladoc Health - GuruFocus
Evercore ISI Raises Teladoc Health (NYSE:TDOC) Price Target to $9.00 - MarketBeat
Best Telemedicine Services That Connect You With Doctors Right Away - CNET
United States Virtual Care Market: 13.2%+ CAGR to US$ 72.73 - openPR.com
United States Telemedicine Market 2025 | Industry Developments, Future Growth, Share & Industry Insights - openPR.com
What drives Teladoc Health Inc stock priceEx-Dividend Date Alerts & Minimal Capital Investment - earlytimes.in
Online Marketplace Stocks Q2 In Review: Teladoc (NYSE:TDOC) Vs Peers - TradingView
Teladoc and Uber Stocks Trade Down, What You Need To Know - The Globe and Mail
Teladoc Health (TDOC): Assessing Valuation After Recent Share Price Swings and Analyst Narratives - Yahoo Finance
Teladoc Health, Inc. $TDOC Position Reduced by Robeco Institutional Asset Management B.V. - MarketBeat
Teladoc (TDOC) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance
All You Need to Know About Teladoc (TDOC) Rating Upgrade to Buy - sharewise.com
Strength Seen in Teladoc (TDOC): Can Its 6.3% Jump Turn into More Strength? - Yahoo Finance
Rising Trends of Mental Health Systems Market Generated Opportunities, Future Scope 2025-2032 - openPR.com
Is Teladoc Health Inc a good long term investmentSupport Zone Identification & High Return Trading Ideas - earlytimes.in
Is Teladoc Health Inc. stock a good hedge against inflationQuarterly Trade Review & High Conviction Buy Zone Alerts - newser.com
Teladoc Health Inc Stock (TDOC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Teladoc Health Inc Stock (TDOC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| DIVITA CHARLES III | CHIEF EXECUTIVE OFFICER |
Sep 11 '25 |
Sale |
7.59 |
16,787 |
127,435 |
179,014 |
3.29%
0.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):